LWAC
CLB icon

Laurel Wealth Advisors (California)’s Core Laboratories CLB Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,310
Closed -$231K – 669
2022
Q1 		$231K Buy
+7,310
New +$205K 0.02% 671
2018
Q4 		– Sell
-2,075
Closed -$240K – 364
2018
Q3 		$240K Buy
2,075
+15
+0.7% +$1.69K 0.06% 338
2018
Q2 		$259K Hold
2,060
– – 0.07% 297
2018
Q1 		$222K Hold
2,060
– – 0.07% 306
2017
Q4 		$225K Buy
2,060
+19
+0.9% +$1.9K 0.06% 310
2017
Q3 		$201K Hold
2,041
– – 0.07% 291
2017
Q2 		$206K Sell
2,041
-30
-1% -$3.23K 0.07% 274
2017
Q1 		$239K Buy
2,071
+65
+3% +$7.55K 0.09% 226
2016
Q4 		$240K Buy
2,006
+20
+1% +$2.21K 0.11% 204
2016
Q3 		$223K Sell
1,986
-146
-7% -$16.8K 0.11% 221
2016
Q2 		$264K Buy
2,132
+75
+4% +$9.05K 0.13% 193
2016
Q1 		$231K Sell
2,057
-145
-7% -$15.1K 0.12% 215
2015
Q4 		$239K Buy
+2,202
New +$252K 0.12% 201

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Laurel Wealth Advisors (California)'s CLB Position: Q2 2022 in Review

Laurel Wealth Advisors (California) sold out of Core Laboratories (CLB) in Q2 2022, closing a stake of 7,310 shares — an estimated $231K sold.

Laurel Wealth Advisors (California) first reported a position in CLB in Q4 2015 and held it in 13 quarters. The position peaked at $264K in Q2 2016. 175 funds tracked by Wall St. Rank hold CLB as of Q2 2022.

  • Laurel Wealth Advisors (California) reported no remaining Core Laboratories position as of Q2 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (California) sold 7,310 Core Laboratories shares in Q2 2022, an estimated $231K.
  • Laurel Wealth Advisors (California) first reported a position in Core Laboratories in Q4 2015 and held it in 13 quarters.
  • Laurel Wealth Advisors (California)'s Core Laboratories position peaked at $264K in Q2 2016.
  • 175 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q2 2022, filed 12 Aug 2022.